| Preferred Name |
taglutimide |
| Synonyms |
K-2004 |
| ID |
http://purl.bioontology.org/ontology/MESH/C006161 |
| altLabel |
K-2004 2-(bicyclo(2.2.1)heptane-2-endo,3-endo-dicarboximido)glutarimide 2-(2,6-dioxo-3-piperidinyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione biglumide |
| cui |
C0124380 C0053573 |
| Has mapping qualifier | |
| HM |
D013792/Q000031 |
| Inverse of RB |
X94T930W1C |
| isa | |
| Mapped to | |
| MDA |
19750101 |
| MeSH Frequency |
4 |
| MMR |
20130510 |
| notation |
C006161 |
| PA |
D000927 D006993 |
| PI |
BICYCLO COMPOUNDS (75-82) |
| prefLabel |
taglutimide |
| RR |
14166-26-8 (biglumide) |
| SC |
1 |
| Scope Statement |
bicyclo analog of thalidomide with teratogenic properties; structure |
| SRC |
Arzneim Forsch 1979;29(8):1146 Arzneim Forsch 24(10):1616;1974 Arch Pharm (Weinheim) 309(8):609;1976 Arch Toxicol 35(1):63;1976 Arzneim Forsch 1979;29(7):1036 Arch Pharm (Weinheim) 311(9):779;1978 Arch Toxicol 37(2):165;1977 |
| TERMUI |
T078361 T078358 T078360 T078359 |
| TH |
NLM (1975) FDA SRS (2013) INN (19XX) |
| tui |
T109 T121 |
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C152491 | National Cancer Institute Thesaurus / 美国国家癌症研究所词典 | LOOM |